| | Varia. | Varia. 5d. | Varia. 1 de ene. | Varia. 1 año | Varia. 3 años | Capi. (M$) |
 | GRACELL BIOTECHNOLOGIES INC. | -0.59% | -10.82% | -44.04% | -70.84% | --.--% | 230 |
| | | | | | | |
| MODERNA, INC. | -0.37% | -8.38% | -32.60% | -56.27% | 1,214.75% | 67 212 |
 | LONZA GROUP AG | -2.36% | 0.69% | -25.13% | -21.02% | 64.32% | 46 073 |
| IQVIA HOLDINGS INC. | 1.57% | 4.72% | -12.88% | -0.18% | 58.15% | 45 135 |
| SEAGEN INC. | -2.24% | -3.23% | 10.05% | 8.93% | 123.54% | 32 099 |
| ALNYLAM PHARMACEUTICALS, INC. | 1.94% | 6.99% | 37.90% | 16.39% | 196.46% | 27 533 |
 | CELLTRION, INC. | -2.12% | 2.21% | 5.05% | -24.63% | 46.60% | 22 493 |
| ICON PUBLIC LIMITED COMPANY | -0.86% | 3.48% | -22.11% | 1.02% | 55.14% | 19 838 |
| BIO-TECHNE CORPORATION | 1.48% | -0.87% | -26.61% | -18.16% | 99.36% | 14 690 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | -0.07% | 3.98% | -15.09% | -29.99% | 101.47% | 13 182 |
| PHARMARON BEIJING CO., LTD. | 0.44% | 2.41% | -18.28% | -44.26% | 229.92% | 12 792 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 2.89% | 4.31% | -38.16% | -42.86% | 79.47% | 11 506 |
| QIAGEN N.V. | 0.28% | 0.44% | -10.18% | -2.27% | 38.90% | 11 335 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.10% | 0.53% | 7.22% | 30.82% | 292.14% | 10 553 |
| UNITED THERAPEUTICS CORPORATION | -1.50% | -2.05% | 0.47% | 6.92% | 167.40% | 10 032 |
 | GENSCRIPT BIOTECH CORPORATION | -0.35% | -7.50% | -17.83% | -16.00% | 59.81% | 7 667 |
| | | | | | | |
| | Promedio | -0.08% | 0.52% | -10.55% | -12.77% | 188.50% | |
| | Media ponderada por Capi. | -0.28% | -0.17% | -12.28% | -17.12% | 315.40% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
